vs
CBIZ, Inc.（CBZ）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是CBIZ, Inc.的1.7倍（$1.4B vs $848.6M），瑞思迈净利率更高（27.6% vs 19.0%，领先8.5%），瑞思迈同比增速更快（11.0% vs 1.3%），过去两年CBIZ, Inc.的营收复合增速更高（42.1% vs 7.8%）
CBIZ, Inc.是美国知名的金融、保险及咨询服务提供商，总部位于俄亥俄州独立市，为美国规模最大的会计、保险经纪、金融与咨询服务机构之一。集团在全美设有120多个办事处，拥有近7000名员工，1996年起在纽交所上市，1997年起使用股票代码CBZ交易。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CBZ vs RMD — 直观对比
营收规模更大
RMD
是对方的1.7倍
$848.6M
营收增速更快
RMD
高出9.7%
1.3%
净利率更高
RMD
高出8.5%
19.0%
两年增速更快
CBZ
近两年复合增速
7.8%
损益表 — Q1 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $848.6M | $1.4B |
| 净利润 | $161.6M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 23.2% | 34.6% |
| 净利率 | 19.0% | 27.6% |
| 营收同比 | 1.3% | 11.0% |
| 净利润同比 | — | 13.9% |
| 每股收益（稀释后） | $2.63 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBZRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $848.6M | $1.4B | ||
| Q4 25 | $542.7M | $1.4B | ||
| Q3 25 | $693.8M | $1.3B | ||
| Q2 25 | $683.5M | $1.3B | ||
| Q1 25 | $838.0M | $1.3B | ||
| Q4 24 | $460.3M | $1.3B | ||
| Q3 24 | $438.9M | $1.2B |
净利润CBZRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | $161.6M | $398.7M | ||
| Q4 25 | $-79.4M | $392.6M | ||
| Q3 25 | $30.1M | $348.5M | ||
| Q2 25 | $41.9M | $379.7M | ||
| Q1 25 | $122.8M | $365.0M | ||
| Q4 24 | $-90.7M | $344.6M | ||
| Q3 24 | $35.1M | $311.4M |
毛利率CBZRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | -9.4% | 61.8% | ||
| Q3 25 | 13.0% | 61.5% | ||
| Q2 25 | 12.9% | 60.8% | ||
| Q1 25 | 27.2% | 59.3% | ||
| Q4 24 | -13.4% | 58.6% | ||
| Q3 24 | 16.6% | 58.6% |
营业利润率CBZRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | 23.2% | 34.9% | ||
| Q4 25 | -15.7% | 34.6% | ||
| Q3 25 | 8.5% | 33.4% | ||
| Q2 25 | 8.8% | 33.7% | ||
| Q1 25 | 23.9% | 33.0% | ||
| Q4 24 | -23.2% | 32.5% | ||
| Q3 24 | 11.3% | 31.6% |
净利率CBZRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | 19.0% | 27.9% | ||
| Q4 25 | -14.6% | 27.6% | ||
| Q3 25 | 4.3% | 26.1% | ||
| Q2 25 | 6.1% | 28.2% | ||
| Q1 25 | 14.7% | 28.3% | ||
| Q4 24 | -19.7% | 26.9% | ||
| Q3 24 | 8.0% | 25.4% |
每股收益（稀释后）CBZRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | $2.63 | $2.74 | ||
| Q4 25 | $-1.22 | $2.68 | ||
| Q3 25 | $0.48 | $2.37 | ||
| Q2 25 | $0.66 | $2.58 | ||
| Q1 25 | $1.91 | $2.48 | ||
| Q4 24 | $-1.84 | $2.34 | ||
| Q3 24 | $0.70 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.7M | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | $1.9B | $6.3B |
| 总资产 | $4.6B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资CBZRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $28.7M | $1.7B | ||
| Q4 25 | $18.3M | $1.4B | ||
| Q3 25 | $17.0M | $1.4B | ||
| Q2 25 | $39.8M | $1.2B | ||
| Q1 25 | $8.8M | $932.7M | ||
| Q4 24 | $13.8M | $521.9M | ||
| Q3 24 | $1.1M | $426.4M |
总债务CBZRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益CBZRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | $1.9B | $6.5B | ||
| Q4 25 | $1.8B | $6.3B | ||
| Q3 25 | $1.9B | $6.1B | ||
| Q2 25 | $1.9B | $6.0B | ||
| Q1 25 | $1.9B | $5.5B | ||
| Q4 24 | $1.8B | $5.3B | ||
| Q3 24 | $927.9M | $5.2B |
总资产CBZRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | $4.6B | $8.8B | ||
| Q4 25 | $4.4B | $8.5B | ||
| Q3 25 | $4.5B | $8.3B | ||
| Q2 25 | $4.5B | $8.2B | ||
| Q1 25 | $4.6B | $7.6B | ||
| Q4 24 | $4.5B | $7.1B | ||
| Q3 24 | $2.1B | $7.2B |
负债/权益比CBZRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-28.5M | — |
| 自由现金流率自由现金流/营收 | -3.4% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | -0.16× | — |
| 过去12个月自由现金流最近4个季度 | $240.5M | — |
8季度趋势，按日历期对齐
经营现金流CBZRMD
| Q2 26 | — | — | ||
| Q1 26 | $-25.5M | — | ||
| Q4 25 | $143.6M | $339.7M | ||
| Q3 25 | $24.0M | $457.3M | ||
| Q2 25 | $113.1M | $538.8M | ||
| Q1 25 | $-88.3M | $578.7M | ||
| Q4 24 | $55.5M | $308.6M | ||
| Q3 24 | $43.7M | $325.5M |
自由现金流CBZRMD
| Q2 26 | — | — | ||
| Q1 26 | $-28.5M | — | ||
| Q4 25 | $141.7M | $311.2M | ||
| Q3 25 | $22.1M | $414.4M | ||
| Q2 25 | $105.2M | $508.2M | ||
| Q1 25 | $-93.4M | $557.9M | ||
| Q4 24 | $52.3M | $288.0M | ||
| Q3 24 | $41.1M | $307.7M |
自由现金流率CBZRMD
| Q2 26 | — | — | ||
| Q1 26 | -3.4% | — | ||
| Q4 25 | 26.1% | 21.9% | ||
| Q3 25 | 3.2% | 31.0% | ||
| Q2 25 | 15.4% | 37.7% | ||
| Q1 25 | -11.2% | 43.2% | ||
| Q4 24 | 11.4% | 22.5% | ||
| Q3 24 | 9.4% | 25.1% |
资本支出强度CBZRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 2.0% | ||
| Q3 25 | 0.3% | 3.2% | ||
| Q2 25 | 1.2% | 2.3% | ||
| Q1 25 | 0.6% | 1.6% | ||
| Q4 24 | 0.7% | 1.6% | ||
| Q3 24 | 0.6% | 1.5% |
现金转化率CBZRMD
| Q2 26 | — | — | ||
| Q1 26 | -0.16× | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | 0.79× | 1.31× | ||
| Q2 25 | 2.70× | 1.42× | ||
| Q1 25 | -0.72× | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 1.25× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBZ
| Financial Services (1) | $740.3M | 87% |
| Benefits and Insurance Services | $108.2M | 13% |
RMD
暂无分部数据
